These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10601737)

  • 21. Structural basis of sequence-specific collagen recognition by SPARC.
    Hohenester E; Sasaki T; Giudici C; Farndale RW; Bächinger HP
    Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18273-7. PubMed ID: 19011090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminaseC-catalyzed modification.
    Hohenadl C; Mann K; Mayer U; Timpl R; Paulsson M; Aeschlimann D
    J Biol Chem; 1995 Oct; 270(40):23415-20. PubMed ID: 7559501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40.
    Nischt R; Pottgiesser J; Krieg T; Mayer U; Aumailley M; Timpl R
    Eur J Biochem; 1991 Sep; 200(2):529-36. PubMed ID: 1653704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40.
    Hohenester E; Maurer P; Timpl R
    EMBO J; 1997 Jul; 16(13):3778-86. PubMed ID: 9233787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of human monocyte matrix metalloproteinases by SPARC.
    Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
    J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testican-3: a brain-specific proteoglycan member of the BM-40/SPARC/osteonectin family.
    Hartmann U; Hülsmann H; Seul J; Röll S; Midani H; Breloy I; Hechler D; Müller R; Paulsson M
    J Neurochem; 2013 May; 125(3):399-409. PubMed ID: 23418755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular calcium-binding protein SPARC/osteonectin in Caenorhabditis elegans.
    Schwarzbauer JE; Musset-Bilal F; Ryan CS
    Methods Enzymol; 1994; 245():257-70. PubMed ID: 7760737
    [No Abstract]   [Full Text] [Related]  

  • 29. Production and purification of recombinant human SPARC.
    Workman G; Bradshaw AD
    Methods Cell Biol; 2018; 143():335-345. PubMed ID: 29310786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
    Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
    J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
    Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
    Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of chicken embryo SPARC (osteonectin).
    Bassuk JA; Iruela-Arispe ML; Lane TF; Benson JM; Berg RA; Sage EH
    Eur J Biochem; 1993 Nov; 218(1):117-27. PubMed ID: 7916692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
    Janusz MJ; Little CB; King LE; Hookfin EB; Brown KK; Heitmeyer SA; Caterson B; Poole AR; Taiwo YO
    Osteoarthritis Cartilage; 2004 Sep; 12(9):720-8. PubMed ID: 15325638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC).
    Rosenblatt S; Bassuk JA; Alpers CE; Sage EH; Timpl R; Preissner KT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):311-9. PubMed ID: 9164872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway.
    Tremble PM; Lane TF; Sage EH; Werb Z
    J Cell Biol; 1993 Jun; 121(6):1433-44. PubMed ID: 8509459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adhesive properties of isolated chick osteocytes in vitro.
    Aarden EM; Nijweide PJ; van der Plas A; Alblas MJ; Mackie EJ; Horton MA; Helfrich MH
    Bone; 1996 Apr; 18(4):305-13. PubMed ID: 8726386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of SPARC (osteonectin, BM-40) with extracellular and intracellular components of the ciliated surface ectoderm of Xenopus embryos.
    Huynh MH; Hong H; Delovitch S; Desser S; Ringuette M
    Cell Motil Cytoskeleton; 2000 Oct; 47(2):154-62. PubMed ID: 11013395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.
    Hughes CE; Caterson B; Fosang AJ; Roughley PJ; Mort JS
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):799-804. PubMed ID: 7531436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC.
    Mann K; Deutzmann R; Paulsson M; Timpl R
    FEBS Lett; 1987 Jun; 218(1):167-72. PubMed ID: 3109947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-ischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia.
    Baumann E; Preston E; Slinn J; Stanimirovic D
    Brain Res; 2009 May; 1269():185-97. PubMed ID: 19285050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.